Abstract
Epidemiological studies show a reduced risk of breast cancer (BC) in women consuming high levels of long-chain (LC) omega-3 (ω-3) fatty acids (FAs) compared with women who consumed low levels. However, the regulatory and mechanistic roles of dietary ω-6 and LC-ω-3 FAs on tumor progression, metastasis and survival are poorly understood. Female BALB/c mice (10-week old) were pair-fed with a diet containing ω-3 or an isocaloric, isolipidic ω-6 diet for 16 weeks prior to the orthotopic implantation of 4T1 mammary tumor cells. Major outcomes studied included: mammary tumor growth, survival analysis, and metastases analyses in multiple organs including pulmonary, hepatic, bone, cardiac, renal, ovarian, and contralateral MG (CMG). The dietary regulation of the tumor microenvironment was evaluated in mice autopsied on day-35 post tumor injection. In mice fed the ω-3 containing diet, there was a significant delay in tumor initiation and prolonged survival relative to the ω-6 diet-fed group. The tumor size on day 35 post tumor injection in the ω-3 group was 50% smaller and the frequencies of pulmonary and bone metastases were significantly lower relative to the ω-6 group. Similarly, the incidence/frequencies and/or size of cardiac, renal, ovarian metastases were significantly lower in mice fed the ω-3 diet. The analyses of the tumor microenvironment showed that tumors in the ω-3 group had significantly lower numbers of proliferating tumor cells (Ki67+)/high power field (HPF), and higher numbers of apoptotic tumor cells (TUNEL+)/HPF, lower neo-vascularization (CD31+ vessels/HPF), infiltration by neutrophil elastase+ cells, and macrophages (F4/80+) relative to the tumors from the ω-6 group. Further, in tumors from the ω-3 diet-fed mice, T-cell infiltration was 102% higher resulting in a neutrophil to T-lymphocyte ratio (NLR) that was 76% lower (p < 0.05). Direct correlations were observed between NLR with tumor size and T-cell infiltration with the number of apoptotic tumor cells. qRT-PCR analysis revealed that tumor IL10 mRNA levels were significantly higher (six-fold) in the tumors from mice fed the ω-3 diet and inversely correlated with the tumor size. Our data suggest that dietary LC-ω-3FAs modulates the mammary tumor microenvironment slowing tumor growth, and reducing metastases to both common and less preferential organs resulting in prolonged survival. The surrogate analyses undertaken support a mechanism of action by dietary LC-ω-3FAs that includes, but is not limited to decreased infiltration by myeloid cells (neutrophils and macrophages), an increase in CD3+ lymphocyte infiltration and IL10 associated anti-inflammatory activity.
Similar content being viewed by others
Change history
03 August 2023
A Correction to this paper has been published: https://doi.org/10.1007/s10585-023-10226-6
Abbreviations
- AA:
-
Arachidonic acid
- BC:
-
Breast cancer
- CBC:
-
Contralateral breast cancer
- CMG:
-
Contralateral mammary gland
- DHA:
-
Docosahexaenoic acid
- EPA:
-
Eicosapentaenoic acid
- FA:
-
Fatty acid
- HO:
-
Histologically observed
- LC:
-
Long-chain
- MFP:
-
Mammary fat pad
- MG:
-
Mammary gland
- NTB:
-
Non-tumor bearing
- NLR:
-
Neutrophil to lymphocyte ratio
- PUFA:
-
Polyunsaturated fatty acid
- qRT-PCR:
-
Quantitative real-time polymerase chain reaction
- TB:
-
Tumor bearing
References
DeSantis CE et al (2017) Breast cancer statistics, 2017, racial disparity in mortality by state. CA Cancer J Clin 67(6):439–448
McCracken M et al (2007) Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities. CA Cancer J Clin 57(4):190–205
Ziegler RG et al (1993) Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 85(22):1819–1827
Evans DG et al (2018) Breast cancer risk in a screening cohort of Asian and white British/Irish women from Manchester UK. BMC Public Health 18(1):178
Zheng J-S et al (2013) Intake of fish and marine n-3 polyunsaturated fatty acids and risk of breast cancer: meta-analysis of data from 21 independent prospective cohort studies. BMJ 346:f3706
Simopoulos AP (2006) Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomed Pharmacother 60(9):502–507
Weylandt KH et al (2012) Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation. Prostaglandins Other Lipid Mediat 97(3–4):73–82
Simopoulos AP (2008) The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med (Maywood) 233(6):674–688
Khadge S et al (2017) Lipid inflammatory mediators in cancer progression and therapy. Adv Exp Med Biol 1036:145–156
D’Eliseo D, Velotti F (2016) Omega-3 fatty acids and cancer cell cytotoxicity: implications for multi-targeted cancer therapy. J Clin Med 5:15
Olivo SE, Hilakivi-Clarke L (2005) Opposing effects of prepubertal low- and high-fat n-3 polyunsaturated fatty acid diets on rat mammary tumorigenesis. Carcinogenesis 26(9):1563–1572
MacLennan MB et al (2013) Mammary tumor development is directly inhibited by lifelong n-3 polyunsaturated fatty acids. J Nutr Biochem 24(1):388–395
Khadge S et al (2018) Long-chain Omega-3 polyunsaturated fatty acids modulate mammary gland composition and inflammation. J Mammary Gland Biol Neoplasia 23(1):43–58
McCormack VA, Silva IdosS (2006) Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomark Prev 15(6):1159–1169
Vaysse C et al (2017) Inflammation of mammary adipose tissue occurs in overweight and obese patients exhibiting early-stage breast cancer. NPJ Breast Cancer 3(1):19
Talmadge JE, Fidler IJ, AACR Centennial Series (2010) The biology of cancer metastasis: historical perspective. Cancer Res 70(14):5649–5669
Fidler IJ (1970) Metastasis: quantitative analysis of distribution and fate of tumor emboli labeled with 125 I-5-iodo-2′-deoxyuridine. J Natl Cancer Inst 45(4):773–782
Paget S (1989) The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev 8(2):98–101
Langley RR, Fidler IJ (2011) The seed and soil hypothesis revisited—the role of tumor-stroma interactions in metastasis to different organs. Int J Cancer J Int du Cancer 128(11):2527–2535
Peters ITA et al (2017) Prevalence and risk factors of ovarian metastases in breast cancer patients < 41 years of age in the Netherlands: A Nationwide Retrospective Cohort Study. PLoS ONE 12(1):e0168277
Bussani R et al (2007) Cardiac metastases. J Clin Pathol 60(1):27–34
Nasu H et al (2015) Breast cancer metastatic to the kidney with renal vein involvement. Jpn J Radiol 33(2):107–111
Tao K et al (2008) Imagable 4T1 model for the study of late stage breast cancer. BMC Cancer 8:228
Hiraga T et al (2004) Zoledronic acid inhibits visceral metastases in the 4T1/luc mouse breast cancer model. Clin Cancer Res 10(13):4559–4567
Zhang Y et al (2015) Surgically-induced multi-organ metastasis in an orthotopic syngeneic imageable model of 4T1 murine breast cancer. Anticancer Res 35(9):4641–4646
Yoneda T et al (2000) Actions of bisphosphonate on bone metastasis in animal models of breast carcinoma. Cancer 88(12 Suppl):2979–2988
Khadge S et al (2018) Dietary omega-3 and omega-6 polyunsaturated fatty acids modulate hepatic pathology. J Nutr Biochem 52:92–102
Watkins BA et al (2000) Dietary ratio of (n-6)/(n-3) polyunsaturated fatty acids alters the fatty acid composition of bone compartments and biomarkers of bone formation in rats. J Nutr 130(9):2274–2284
Yuan J et al (2010) The effects of polyunsaturated fatty acids and their metabolites on osteoclastogenesis in vitro. Prostaglandins Other Lipid Mediat 92(1–4):85–90
Wonnacott KE et al (2010) Dietary omega-3 and -6 polyunsaturated fatty acids affect the composition and development of sheep granulosa cells, oocytes and embryos. Reproduction 139(1):57–69
Khan RS et al (2013) Fish oil selectively improves heart function in a mouse model of lipid-induced cardiomyopathy. J Cardiovasc Pharmacol 61(4):345–354
Zeng Z et al (2017) Omega-3 polyunsaturated fatty acids attenuate fibroblast activation and kidney fibrosis involving MTORC2 signaling suppression. Sci Rep 7:46146
Aslakson CJ, Miller FR (1992) Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res 52(6):1399–1405
Talmadge JE (2010) Models of metastasis in drug discovery. Methods Mol Biol 602:215–233
Younos IH et al (2012) Tumor regulation of myeloid-derived suppressor cell proliferation and trafficking. Int Immunopharmacol 13(3):245–256
Lelekakis M et al (1999) A novel orthotopic model of breast cancer metastasis to bone. Clin Exp Metastasis 17(2):163–170
Heppner H, Miller GFR, Malathy PV, Shekhar (2000) Nontransgenic models of breast cancer. Breast Cancer Res 2(5):331–334
Morecki S et al (1998) Allogeneic cell therapy for a murine mammary carcinoma. Cancer Res 58(17):3891–3895
Faria SS et al (2016) The neutrophil-to-lymphocyte ratio: a narrative review. Ecancermedicalscience 10:702
Kim EJ et al (2011) Dietary fat increases solid tumor growth and metastasis of 4T1 murine mammary carcinoma cells and mortality in obesity-resistant BALB/c mice. Breast Cancer Res 13(4):R78–R78
Buckley JD, Howe PR (2009) Anti-obesity effects of long-chain omega-3 polyunsaturated fatty acids. Obes Rev 10(6):648–659
Amri EZ, Ailhaud G, Grimaldi PA (1994) Fatty acids as signal transducing molecules: involvement in the differentiation of preadipose to adipose cells. J Lipid Res 35(5):930–937
Bing C et al (2006) Adipose atrophy in cancer cachexia: morphologic and molecular analysis of adipose tissue in tumour-bearing mice. Br J Cancer 95(8):1028–1037
Porporato PE (2016) Understanding cachexia as a cancer metabolism syndrome. Oncogenesis 5:e200
Ebadi M, Mazurak VC (2014) evidence and mechanisms of fat depletion in Cancer. Nutrients 6(11):5280–5297
Yee LD et al (2005) Dietary (n-3) polyunsaturated fatty acids inhibit HER-2/neu-induced breast cancer in mice independently of the PPARgamma ligand rosiglitazone. J Nutr 135(5):983–988
Yee LD et al (2013) The inhibition of early stages of HER-2/neu-mediated mammary carcinogenesis by dietary n-3 PUFAs. Mol Nutr Food Res 57(2):320–327
Olivo-Marston SE et al (2008) Gene signaling pathways mediating the opposite effects of prepubertal low-fat and high-fat n-3 polyunsaturated fatty acid diets on mammary cancer risk. Cancer Prev Res (Phila) 1(7):532–545
Paschall AV, Liu K (2016) An orthotopic mouse model of spontaneous breast cancer metastasis. J Visualized Exp: JoVE. https://doi.org/10.3791/54040
Ghochikyan A et al (2014) Primary 4T1 tumor resection provides critical “window of opportunity” for immunotherapy. Clin Exp Metastasis 31(2):185–198
Chung H et al (2014) Omega-3 fatty acids reduce obesity-induced tumor progression independent of GPR120 in a mouse model of postmenopausal breast cancer. Oncogene 34:3504
Xue M et al (2014) Docosahexaenoic acid inhibited the Wnt/beta-catenin pathway and suppressed breast cancer cells in vitro and in vivo. J Nutr Biochem 25(2):104–110
Pulaski BA, Ostrand-Rosenberg S (1998) Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccines. Can Res 58(7):1486–1493
Saxena M, Christofori G (2013) Rebuilding cancer metastasis in the mouse. Mol Oncol 7(2):283–296
Wright LE et al (2016) Murine models of breast cancer bone metastasis. BoneKEy Rep 5:804
Bolin C et al (2012) Novel mouse mammary cell lines for in vivo bioluminescence imaging (BLI) of bone metastasis. Biol Proced Online 14:6–6
Mandal CC et al (2010) Fish oil prevents breast cancer cell metastasis to bone. Biochem Biophys Res Commun 402(4):602–607
Rahman M et al (2013) DHA is a more potent inhibitor of breast cancer metastasis to bone and related osteolysis than EPA. Breast Cancer Res Treat. https://doi.org/10.1007/s10549-013-2703-y
Kruger MC, Schollum LM (2005) Is docosahexaenoic acid more effective than eicosapentaenoic acid for increasing calcium bioavailability? Prostaglandins Leukot Essent Fatty Acids 73(5):327–334
Watkins BA, Li Y, Seifert MF (2006) Dietary ratio of n-6/n-3 PUFAs and docosahexaenoic acid: actions on bone mineral and serum biomarkers in ovariectomized rats. J Nutr Biochem 17(4):282–289
Huo Z et al (2015) Metastasis of breast cancer to renal cancer: report of a rare case. Int J Clin Exp Pathol 8(11):15417–15421
Kline IK (1972) Cardiac lymphatic involvement by metastatic tumor. Cancer 29(3):799–808
Lockwood WB, Broghamer WL (1980) The changing prevalence of secondary cardiac neoplasms as related to cancer therapy. Cancer 45(10):2659–2662
Reynen K, Köckeritz U, Strasser RH (2004) Metastases to the heart. Ann Oncol 15(3):375–381
PIMENTEL C et al (2016) Ovarian metastases from breast cancer: a series of 28 cases. Anticancer Res 36(8):4195–4200
Lee S-J et al (2009) Clinical characteristics of metastatic tumors to the ovaries. J Korean Med Sci 24(1):114–119
Eilati E et al (2013) Flaxseed enriched diet-mediated reduction in ovarian cancer severity is correlated to the reduction of prostaglandin E2 in laying hen ovaries. Prostaglandins Leukot Essent Fatty Acids (PLEFA) 89(4):179–187
Wan XH, Fu X, Ababaikeli G (2016) Docosahexaenoic acid induces growth suppression on epithelial ovarian cancer cells more effectively than eicosapentaenoic acid. Nutr Cancer 68(2):320–327
Wang Y-C et al (2016) Docosahexaenoic acid modulates invasion and metastasis of human ovarian cancer via multiple molecular pathways. Int J Gynecol Cancer 26(6):994–1003
Chen Y et al (1999) Epidemiology of contralateral breast cancer. Cancer Epidemiol Biomark Prevent 8(10):855–861
Alkner S et al (2015) Contralateral breast cancer can represent a metastatic spread of the first primary tumor: determination of clonal relationship between contralateral breast cancers using next-generation whole genome sequencing. Breast Cancer Res 17(1):102
Raghavendra A et al (2017) Mammographic breast density is associated with the development of contralateral breast cancer. Cancer 123(11):1935–1940
Khadge S et al (2018) Long-chain omega-3 polyunsaturated fatty acids modulate mammary gland composition and inflammation. J Mammary Gland Biol Neoplasia. https://doi.org/10.1007/s10911-018-9391-5
Schley PD et al (2005) Mechanisms of omega-3 fatty acid-induced growth inhibition in MDA-MB-231 human breast cancer cells. Breast Cancer Res Treat 92(2):187–195
Jiang W et al (2012) Identification of a molecular signature underlying inhibition of mammary carcinoma growth by dietary N-3 fatty acids. Can Res 72(15):3795–3806
El Fadli M et al (2017) Breast cancer metastasis to the spleen: a case report and literature review. Oxford Med Case Rep 2017(12):omx069
Roomi MW et al (2014) In vitro and in vivo effects of a nutrient mixture on breast cancer progression. Int J Oncol 44(6):1933–1944
DuPre SA, Hunter KW Jr (2007) Murine mammary carcinoma 4T1 induces a leukemoid reaction with splenomegaly: association with tumor-derived growth factors. Exp Mol Pathol 82(1):12–24
Talmadge JE, Gabrilovich DI (2013) History of myeloid derived suppressor cells (MDSCs) in the macro- and micro-environment of tumour-bearing hosts. Nat Rev Cancer 13(10):739–752
Younos I et al (2011) Tumor- and organ-dependent infiltration by myeloid-derived suppressor cells. Int Immunopharmacol 11(7):816–826
Gonzalez MJ et al (1993) Dietary fish oil inhibits human breast carcinoma growth: a function of increased lipid peroxidation. Lipids 28(9):827–832
Hammamieh R et al (2007) Control of the growth of human breast cancer cells in culture by manipulation of arachidonate metabolism. BMC Cancer 7(1):138
Albino AP et al (2000) Cell cycle arrest and apoptosis of melanoma cells by docosahexaenoic acid: association with decreased pRb phosphorylation. Can Res 60(15):4139–4145
Istfan NW, Wan J, Chen ZY (1995) Fish oil and cell proliferation kinetics in a mammary carcinoma tumor model. Adv Exp Med Biol 375:149–156
Murray M et al (2015) Anti-tumor activities of lipids and lipid analogues and their development as potential anticancer drugs. Pharmacol Ther 150:109–128
Merendino N et al (2013) Dietary ω-3 polyunsaturated fatty acid DHA: a potential adjuvant in the treatment of cancer. BioMed Res Int. https://doi.org/10.1155/2013/310186
Hardman WE et al (2001) Three percent dietary fish oil concentrate increased efficacy of doxorubicin against MDA-MB 231 breast cancer xenografts. Clin Cancer Res 7(7):2041–2049
Reddy S, Raffin M, Kaklamani V (2012) Targeting angiogenesis in metastatic breast cancer. Oncologist 17(8):1014–1026
Fidler IJ, Ellis LM (1994) The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 79(2):185–188
Zhang G et al (2013) Epoxy metabolites of docosahexaenoic acid (DHA) inhibit angiogenesis, tumor growth, and metastasis. Proc Natl Acad Sci USA 110(16):6530–6535
Albini A et al (2005) Tumor inflammatory angiogenesis and its chemoprevention. Cancer Res 65(23):10637–10641
Lewis CE et al (1995) Cytokine regulation of angiogenesis in breast cancer: the role of tumor-associated macrophages. J Leukoc Biol 57(5):747–751
Nozawa H, Chiu C, Hanahan D, (2006) Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc Natl Acad Sci USA 103(33):12493–12498
Wroblewski M et al (2017) Mast cells decrease efficacy of anti-angiogenic therapy by secreting matrix-degrading granzyme B. Nat Commun 8(1):269
Liang P et al (2016) Effect of dietary omega-3 fatty acids on tumor-associated macrophages and prostate cancer progression. Prostate 76(14):1293–1302
Kzhyshkowska J et al (2014) Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis. Front Physiol. https://doi.org/10.3389/fphys.2014.00075
Mantovani A, Locati M (2016) Macrophage metabolism shapes angiogenesis in tumors. Cell Metab 24(5):653–654
Bingle L et al (2005) Macrophages promote angiogenesis in human breast tumour spheroids in vivo. Br J Cancer 94:101
Denkert C et al (2010) Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer. J Clin Oncol 28(1):105–113
Zhang X, Xu W (2017) Neutrophils diminish T-cell immunity to foster gastric cancer progression: the role of GM-CSF/PD-L1/PD-1 signalling pathway. Gut. https://doi.org/10.1136/gutjnl-2017-313923
Wei B et al (2016) The neutrophil lymphocyte ratio is associated with breast cancer prognosis: an updated systematic review and meta-analysis. OncoTargets Ther 9:5567–5575
Jiao Y et al (2017) Docosahexaenoic acid and disulfiram act in concert to kill cancer cells: a mutual enhancement of their anticancer actions. Oncotarget 8(11):17908–17920
Hajjaji N, Bougnoux P (2013) Selective sensitization of tumors to chemotherapy by marine-derived lipids: a review. Cancer Treat Rev 39(5):473–488
Slagsvold JE et al (2010) DHA alters expression of target proteins of cancer therapy in chemotherapy resistant SW620 colon cancer cells. Nutr Cancer 62(5):611–621
Hamidullah B, Changkija, Konwar R (2012) Role of interleukin-10 in breast cancer. Breast Cancer Res Treat 133(1):11–21
Bhattacharjee HK et al (2016) Is Interleukin 10 (IL10) expression in breast cancer a marker of poor prognosis? Indian J Surg Oncol 7(3):320–325
Ahmad N et al (2018) IL-6 and IL-10 are associated with good prognosis in early stage invasive breast cancer patients. Cancer Immunol Immunother 67(4):537–549
Fujii S et al (2001) Interleukin-10 promotes the maintenance of antitumor CD8(+) T-cell effector function in situ. Blood 98(7):2143–2151
Mumm JB et al (2011) IL-10 elicits IFNgamma-dependent tumor immune surveillance. Cancer Cell 20(6):781–796
Sun Z et al (2015) IL10 and PD-1 cooperate to limit the activity of tumor-specific CD8+ T Cells. Cancer Res 75(8):1635–1644
Bradley RL, Fisher FM, Eleftheria MF (2008) Dietary fatty acids differentially regulate production of TNF-α and IL-10 by Murine 3T3-L1 Adipocytes. Obesity 16(5):938–944
Foitzik T et al (2002) Omega-3 fatty acid supplementation increases anti-inflammatory cytokines and attenuates systemic disease sequelae in experimental pancreatitis. JPEN J Parenter Enteral Nutr 26(6):351–356
Donkor MK et al (2009) Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells. Int Immunopharmacol 9(7–8):937–948
Kowanetz M et al (2010), Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+ Ly6C+ granulocytes. Proc Natl Acad Sci USA 107(50):21248–21255
Roche-Nagle G et al (2004) Antimetastatic activity of a cyclooxygenase-2 inhibitor. Br J Cancer 91:359
Brault MS, Kurt RA (2005) Impact of tumor-derived CCL2 on macrophage effector function. J Biomed Biotechnol 2005(1):37–43
Waight JD et al (2011) Tumor-derived G-CSF facilitates neoplastic growth through a granulocytic myeloid-derived suppressor cell-dependent mechanism. PLoS ONE 6(11):e27690
Acknowledgements
We gratefully acknowledge funding from the Fred & Pamela Buffett Cancer Center’s NIH Cancer Center Support Grant No. (P30CA036727) and the Nebraska Center for Integrated Biomolecular Communications (Grant No. P20GM113126) for this project. Also, funding from the UNMC College of Medicine (LWK) Endowed Chair.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there are no conflicts of interest.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Khadge, S., Thiele, G.M., Sharp, J.G. et al. Long-chain omega-3 polyunsaturated fatty acids decrease mammary tumor growth, multiorgan metastasis and enhance survival. Clin Exp Metastasis 35, 797–818 (2018). https://doi.org/10.1007/s10585-018-9941-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10585-018-9941-7